Biotest is committed to combating the coronavirus

Activities of Biotest Group against the coronavirus

TV reports, press releases and the presentation of Biotest's research activities.

CoVIg-19 PLASMA ALLIANCE

Our product range

Our development pipeline

Phase 1

Phase 2

Phase 3

Approval

Launch

IgG Next Generation (BT595) - Primary Immune Deficiency (PID)
IgG Next Generation (BT595) - Idiopathic Thrombocytopenic Purpura (ITP)
CMV Hyperimmunglobulin ((CMVIG) ) - Prevention of prenatal CMV transmission
Fibrinogen (BT524) - Congenital fibrinogen deficiency
Fibrinogen (BT524) - Acquired fibrinogen deficiency
Trimodulin (BT588) - Severe community acquired pneumonia
Haemophilia A Therapeutic (HAT) - Haemophilia A

Pipeline

Pipeline

Press releases

Biotest AG opens eighth plasma collection centre in Cze...

12.01.2022,

12.01.2022 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Release according to Article 40, Section 1 of the WpHG ...

10.01.2022,

10.01.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.Archive at ... ... [More]

Grifols, S.A. will hold more than 95,5498 % of the voti...

07.01.2022,

Announcement according to Article 17 European Market Abuse Regulation (MAR)Grifols, S.A. will hold more than 95,5498 % of the voting rights upon settlement of the takeover offerDreieich, 7 January 202 ... [More]

Biotest treats first CMV-positive pregnant woman in Pha...

14.12.2021,

14.12.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest Supervisory Board appoints new Management Board...

09.12.2021,

09.12.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest adjusts guidance

08.12.2021,

08.12.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Reduction of guidance

08.12.2021,

Announcement according to Article 17 European Market Abuse Regulation (MAR)Dreieich, 08 Dezember 2021. Due to the changing market environment for the plasmatic coagulation factor VIII, the Supervisory ... [More]

Biotest receives approval for Intratect(R) in France

30.11.2021,

30.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest AG opens seventh plasma collection centre in Cz...

25.11.2021,

25.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest accelerates trimodulin development in hospitali...

23.11.2021,

23.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Cytotect CP(R) Biotest activates immune cells that are ...

16.11.2021,

16.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest increases sales by 9% in the first nine months ...

11.11.2021,

11.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Joint reasoned statement of Biotest AG - Management Boa...

05.11.2021,

05.11.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest identifies a benefit with trimodulin in a relev...

11.10.2021,

11.10.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Release according to Article 40, Section 1 of the WpHG ...

20.09.2021,

20.09.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at ... ... [More]

Takeover Offer: Grifols S.A. to make a voluntary public...

17.09.2021,

Announcement according to Article 17 European Market Abuse Regulation (MAR)Takeover Offer: Grifols S.A. to make a voluntary public takeover offer for the shares of Biotest AGDreieich, 17 September 202 ... [More]

Biotest announces the new Renate & Hans Schleussner Awa...

15.09.2021,

15.09.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest receives approval for phase III clinical trial ...

26.08.2021,

26.08.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Biotest AG opens sixth plasma collection centre in Czec...

23.08.2021,

23.08.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Trimodulin does not reach the primary endpoint in the p...

13.08.2021,

13.08.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.The issuer is solely responsible for the content of this announcement.The DGAP Distribution Services incl ... [More]

Careers

Careers

Passionate to help us save lives?

Investor Relations

Investor Relations

The primary objective of our Investor Relations activities is an open and up-to-date dialogue with the financial community.